Theravance Biopharma Inc.

NASDAQ: TBPH · Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT

Theravance Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.42M -55.19M -92.82M -199.43M
Depreciation & Amortization
3.62M 4.26M 7.02M 9.71M
Stock-Based Compensation
21.39M 25.37M 39.73M 62.06M
Other Working Capital
20.57M -8.35M 46.68M -11.46M
Other Non-Cash Items
7.09M 3.7M -183.28M 3.86M
Deferred Income Tax
-7.57M 3.21M n/a -44.48M
Change in Working Capital
20.36M -8.34M 42.35M -39.58M
Operating Cash Flow
-11.54M -27M -186.99M -207.86M
Capital Expenditures
-332K -2.49M -572K -3.41M
Cash Acquisitions
n/a n/a 4.58M 6K
Purchase of Investments
-143.03M -134.53M -103.14M -158.31M
Sales Maturities Of Investments
155.65M 102.81M 158.02M 286.2M
Other Investing Acitivies
n/a 1.51M 1.1B 127.9M
Investing Cash Flow
12.28M -32.7M 1.15B 124.49M
Debt Repayment
n/a n/a -631.6M -10.73M
Common Stock Repurchased
-3.1M -199.55M -132.28M -9.06M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
508K 618K 5.08M 3.47M
Financial Cash Flow
-2.5M -198.93M -758.81M 91.86M
Net Cash Flow
-1.75M -258.63M 208.21M 8.5M
Free Cash Flow
-11.87M -29.48M -187.56M -211.26M